These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8617484

  • 1. Atypical adenomatous hyperplasia (adenosis) of the prostate: development of a Bayesian belief network for its distinction from well-differentiated adenocarcinoma.
    Montironi R, Bartels PH, Hamilton PW, Thompson D.
    Hum Pathol; 1996 Apr; 27(4):396-407. PubMed ID: 8617484
    [Abstract] [Full Text] [Related]

  • 2. Prostatic intraepithelial neoplasia (PIN). Performance of Bayesian belief network for diagnosis and grading.
    Montironi R, Bartels PH, Thompson D, Scarpelli M, Hamilton PW.
    J Pathol; 1995 Oct; 177(2):153-62. PubMed ID: 7490682
    [Abstract] [Full Text] [Related]

  • 3. Prostatic intraepithelial neoplasia. Development of a Bayesian belief network for diagnosis and grading.
    Montironi R, Bartels PH, Thompson D, Scarpelli M, Hamilton PW.
    Anal Quant Cytol Histol; 1994 Apr; 16(2):101-12. PubMed ID: 8043157
    [Abstract] [Full Text] [Related]

  • 4. Urothelial papillary lesions. Development of a Bayesian Belief Network for diagnosis and grading.
    Mazzucchelli R, Santinelli A, Colanzi P, Streccioni M, Lopez-Beltran A, Scarpelli M, Montironi R.
    Anticancer Res; 2001 Apr; 21(2A):1157-62. PubMed ID: 11396156
    [Abstract] [Full Text] [Related]

  • 5. Androgen-deprived prostate adenocarcinoma: evaluation of treatment-related changes versus no distinctive treatment effect with a Bayesian belief network. A methodological approach.
    Montironi R, Bartels PH, Thompson D, Diamanti L, Prete E.
    Eur Urol; 1996 Apr; 30(3):307-15. PubMed ID: 8931962
    [Abstract] [Full Text] [Related]

  • 6. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma.
    Bostwick DG, Srigley J, Grignon D, Maksem J, Humphrey P, van der Kwast TH, Bose D, Harrison J, Young RH.
    Hum Pathol; 1993 Aug; 24(8):819-32. PubMed ID: 8375853
    [Abstract] [Full Text] [Related]

  • 7. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
    Helpap B, Riede C.
    Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
    [Abstract] [Full Text] [Related]

  • 8. Bayesian belief network for the Gleason patterns in prostatic adenocarcinoma: development of a diagnostic decision support system for educational purposes.
    Montironi R, Ball RY, Griffiths DF, Grigor K, Harnden PM, Jarmulowicz M, McWilliam LJ, Moseley RP, Parkinson MC, Santinelli A, Moss SM, Melia JW.
    Anal Quant Cytol Histol; 2008 Feb; 30(1):8-15. PubMed ID: 18459582
    [Abstract] [Full Text] [Related]

  • 9. Adenosis (atypical adenomatous hyperplasia): histopathology and relationship to carcinoma.
    Epstein JI.
    Pathol Res Pract; 1995 Sep; 191(9):888-98. PubMed ID: 8606870
    [Abstract] [Full Text] [Related]

  • 10. Subtle changes in benign tissue adjacent to prostate neoplasia detected with a Bayesian belief network.
    Montironi R, Diamanti L, Pomante R, Thompson D, Bartels PH.
    J Pathol; 1997 Aug; 182(4):442-9. PubMed ID: 9306966
    [Abstract] [Full Text] [Related]

  • 11. Nuclear volume estimates in prostatic atypical adenomatous hyperplasia.
    López-Beltrán A, Artacho-Pérula E, Luque-Barona RJ, Roldán-Villalobos R.
    Anal Quant Cytol Histol; 2000 Dec; 22(6):438-44. PubMed ID: 11147297
    [Abstract] [Full Text] [Related]

  • 12. Nucleolar prominence as a diagnostic variable in prostatic carcinoma.
    Kelemen PR, Buschmann RJ, Weisz-Carrington P.
    Cancer; 1990 Feb 15; 65(4):1017-20. PubMed ID: 1688728
    [Abstract] [Full Text] [Related]

  • 13. Atypical adenomatous hyperplasia of the prostate mimicking adenocarcinoma lesion: case report and literature review.
    Enciu M, Aşchie M, Boşoteanu M, Chisoi A.
    Rom J Morphol Embryol; 2012 Feb 15; 53(4):1093-6. PubMed ID: 23303039
    [Abstract] [Full Text] [Related]

  • 14. Adenosis of the prostate. Histologic features in transurethral resection specimens.
    Gaudin PB, Epstein JI.
    Am J Surg Pathol; 1994 Sep 15; 18(9):863-70. PubMed ID: 7520673
    [Abstract] [Full Text] [Related]

  • 15. Case diagnosis as positive identification in prostatic neoplasia.
    Montironi R, Mazzucchelli R, Santinelli A, Hamilton PW, Thompson D, Bartels PH.
    Anal Quant Cytol Histol; 1998 Oct 15; 20(5):424-36. PubMed ID: 9801761
    [Abstract] [Full Text] [Related]

  • 16. Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases.
    Malpica A, Ro JY, Troncoso P, Ordoñez NG, Amin MB, Ayala AG.
    Hum Pathol; 1994 Apr 15; 25(4):390-5. PubMed ID: 7512941
    [Abstract] [Full Text] [Related]

  • 17. Associations among benign prostate hypertrophy, atypical adenomatous hyperplasia and latent carcinoma of the prostate.
    Stamatiou K, Alevizos A, Natzar M, Mihas C, Mariolis A, Michalodimitrakis E, Sofras F.
    Asian J Androl; 2007 Mar 15; 9(2):229-33. PubMed ID: 16751999
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic limits in precursor lesions of prostatic cancer.
    Algaba F, Trias I.
    Eur Urol; 1996 Mar 15; 30(2):212-21. PubMed ID: 8875203
    [Abstract] [Full Text] [Related]

  • 19. Is atypical adenomatous hyperplasia of the prostate a precursor lesion?
    Zhang C, Montironi R, MacLennan GT, Lopez-Beltran A, Li Y, Tan PH, Wang M, Zhang S, Iczkowski KA, Cheng L.
    Prostate; 2011 Dec 15; 71(16):1746-51. PubMed ID: 21480308
    [Abstract] [Full Text] [Related]

  • 20. Belief network for grading prostate lesions.
    Bibbo M, Bartels PH, Pfeifer T, Thompson D, Minimo C, Davidson HG.
    Anal Quant Cytol Histol; 1993 Apr 15; 15(2):124-35. PubMed ID: 8318127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.